Finger-tapping test is a psychomotor evaluation tool for healthcare professionals and athletes, available as a paid iOS app.
The App DNA
What makes this app unique?
Users hire this app to quantify concentration and motor coordination using specific psychomotor protocols that are otherwise difficult to measure manually.
For Healthcare professionals conducting clinical assessments and athletes seeking to track motor performance.
What does it look like?
Key features
Psychomotor evaluation tool measuring concentration, reaction time, and motor coordination based on E.P. Ilyin and M.V. Grigoriev methodologies
Provides detailed psychomotor metrics for interpretation and decision-making in clinical or athletic settings
How much does it cost?
Low-cost, one-time purchase model targets mass-market accessibility for a niche reference tool.
Velocity
Steady developmentShow more...
Who built it?
Roman Kuryanov
12 apps tracked · Reference
Roman: budget weight loss
DJ Meow: Piano for Kids
Mama’s Farm: Calm & Cozy
Oh My Pool! Everlasting summer
Islamic Prayer & Qibla Compass
Quntact: Business Card Scanner
GoodDeed
tottler: Parents helper
Gamemory - Augmented Reality
Pixel Beard
Mishep — workout with friendsUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Finger-tapping test
How's the Reference market?
The app maintains a presence in the Reference category across multiple European markets, including Ireland (#7) and Denmark (#8), though it shows volatility with a #98 entry in the US market. The low price point suggests a focus on individual user acquisition rather than enterprise clinical sales.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Finger-tapping test
Where is it heading?
Users report: The psychomotor assessment market is consolidating around tools that offer seamless data integration, leaving standalone utilities like Finger-tapping test exposed. Future growth depends on transitioning from a simple testing tool to a data-management platform for clinicians.
- The app maintains a steady niche presence in European markets, but the lack of feature expansion limits growth potential beyond the current user base.
The SWOT
- Niche psychomotor methodology provides a specialized utility for targeted clinical and athletic segments
- Low-cost, one-time purchase model lowers the barrier to entry for individual practitioners and athletes
- Partnerships with athletic training programs could establish the app as a standard performance-tracking tool
- Expansion into broader cognitive health metrics could increase the total addressable market
Next best moves
Ship professional data-export features because clinical users require integration with external records → increase professional adoption
The counter-intuitive read
The app's low price is its greatest liability: by pricing at $0.
Read the full takeSince the last report: The app transitioned from an undefined paid utility to a specific $0.39 one-time purchase model, with new analysis highlighting the risks this low price poses to clinical adoption.
Bottom line
Finger-tapping test provides a specialized psychomotor evaluation tool at an accessible price point, but its lack of professional integration limits its clinical adoption, so the PM should prioritize building a B2B data-export feature to increase utility for healthcare professionals.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated